Matches in Wikidata for { <http://www.wikidata.org/entity/Q92030796> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- Q92030796 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q92030796 description "im Dezember 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92030796 description "scientific article published on 17 December 2019" @default.
- Q92030796 description "wetenschappelijk artikel" @default.
- Q92030796 description "наукова стаття, опублікована 17 грудня 2019" @default.
- Q92030796 name "A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)" @default.
- Q92030796 name "A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)" @default.
- Q92030796 type Item @default.
- Q92030796 label "A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)" @default.
- Q92030796 label "A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)" @default.
- Q92030796 prefLabel "A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)" @default.
- Q92030796 prefLabel "A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)" @default.
- Q92030796 P1433 Q92030796-D19C75C5-2EB5-46B1-82F4-D34167CAF716 @default.
- Q92030796 P1476 Q92030796-B345295D-FA8A-4CF9-B9B9-87667B0A2F4D @default.
- Q92030796 P2093 Q92030796-26E8B3A8-B24C-40CC-BB6C-61F9D3815515 @default.
- Q92030796 P2093 Q92030796-2A91C595-6576-4D83-B239-C5DFF7BB4739 @default.
- Q92030796 P2093 Q92030796-30660540-AB28-498B-B47E-E65B57E70236 @default.
- Q92030796 P2093 Q92030796-67AD995D-4ADE-428B-A85F-7CF8A005F8EA @default.
- Q92030796 P2093 Q92030796-6CE6D29C-7D01-4F80-A8DF-F9E1BB2F4FC7 @default.
- Q92030796 P2093 Q92030796-7173C54A-C401-4633-84D9-7440781FFBB1 @default.
- Q92030796 P2093 Q92030796-7CD4FACF-B2AD-4873-B81D-2EE1EAAA5920 @default.
- Q92030796 P2093 Q92030796-905F2BFF-F476-4C9C-BD48-132F4B06BE1F @default.
- Q92030796 P2093 Q92030796-B3E3724F-1913-4097-865F-C3FA99F23208 @default.
- Q92030796 P2093 Q92030796-CAE0F3A3-70B7-42C6-89E1-39503CEA063E @default.
- Q92030796 P2093 Q92030796-D092056C-D3C9-4F39-BAEC-242EE8F9E370 @default.
- Q92030796 P2093 Q92030796-D93D22B4-EFAF-4B50-BD2A-1D60B2FEB1E6 @default.
- Q92030796 P275 Q92030796-ad5e3953-4751-45b7-9a6c-07e1cfc5f8f9 @default.
- Q92030796 P31 Q92030796-90274D35-8AB3-4FAA-9D10-CC2554ABB514 @default.
- Q92030796 P356 Q92030796-97748A83-F90F-4D88-ACE3-CB9538D8CC94 @default.
- Q92030796 P50 Q92030796-B97B00AF-CBF6-4AD7-9B51-D03FE7E4FE82 @default.
- Q92030796 P50 Q92030796-D9653DC9-73FB-4D2D-B5C8-65246BA102EC @default.
- Q92030796 P577 Q92030796-1BE9AEFF-6D37-4F1A-BC4F-A8318A772CB6 @default.
- Q92030796 P6216 Q92030796-a3a9739c-23b0-4111-86c1-67500b3cab94 @default.
- Q92030796 P698 Q92030796-1F220DA2-5F97-4E4D-8795-433D51630F5B @default.
- Q92030796 P921 Q92030796-0B55DEC2-700A-47E5-A395-F420C6A7DE04 @default.
- Q92030796 P921 Q92030796-A8ABC5CF-93A4-4BFC-B9B1-8CEE0F4E3443 @default.
- Q92030796 P356 NOZ232 @default.
- Q92030796 P698 31844890 @default.
- Q92030796 P1433 Q15724471 @default.
- Q92030796 P1476 "A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)" @default.
- Q92030796 P2093 "Andrew Brenner" @default.
- Q92030796 P2093 "Benjamin M Ellingson" @default.
- Q92030796 P2093 "GLOBE Study Investigators" @default.
- Q92030796 P2093 "Jian L Campian" @default.
- Q92030796 P2093 "John F de Groot" @default.
- Q92030796 P2093 "Laurence S Freedman" @default.
- Q92030796 P2093 "Leor Zach" @default.
- Q92030796 P2093 "Nicholas A Butowski" @default.
- Q92030796 P2093 "Noa Lowenton-Spier" @default.
- Q92030796 P2093 "Shifra Fain Shmueli" @default.
- Q92030796 P2093 "Tamar Rachmilewitz Minei" @default.
- Q92030796 P2093 "Yael C Cohen" @default.
- Q92030796 P275 Q20007257 @default.
- Q92030796 P31 Q13442814 @default.
- Q92030796 P356 "10.1093/NEUONC/NOZ232" @default.
- Q92030796 P50 Q105531697 @default.
- Q92030796 P50 Q47159504 @default.
- Q92030796 P577 "2019-12-17T00:00:00Z" @default.
- Q92030796 P6216 Q50423863 @default.
- Q92030796 P698 "31844890" @default.
- Q92030796 P921 Q282142 @default.
- Q92030796 P921 Q413299 @default.